Hou J - Search Results

1

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B.

Wang Y, Thongsawat S, Gane EJ, Liaw YF, Jia J, Hou J, Chan HL, Papatheodoridis G, Wan M, Niu J, Bao W, Trylesinski A, Naoumov NV. Wang Y, et al. Among authors: hou j. J Viral Hepat. 2013 Apr;20(4):e37-46. doi: 10.1111/jvh.12025. Epub 2012 Dec 27. J Viral Hepat. 2013. PMID: 23490388 Free PMC article. Clinical Trial.

2

Clinical and histological characteristics of chronic hepatitis B with negative hepatitis B e-antigen.

Peng J, Luo K, Zhu Y, Guo Y, Zhang L, Hou J. Peng J, et al. Among authors: hou j. Chin Med J (Engl). 2003 Sep;116(9):1312-7. Chin Med J (Engl). 2003. PMID: 14527355

3

[A study of the causes of poor antiviral responses in male chronic hepatitis B patients treated with recombinant interferon-alpha].

Mao QG, Liu DL, Zhang MX, Feng XR, Hou JL. Mao QG, et al. Zhonghua Gan Zang Bing Za Zhi. 2005 Jan;13(1):24-6. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15670486 Chinese.

4

A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China.

Wang Z, Liu Z, Zeng G, Wen S, Qi Y, Ma S, Naoumov NV, Hou J. Wang Z, et al. Among authors: hou j. J Gen Virol. 2005 Apr;86(Pt 4):985-990. doi: 10.1099/vir.0.80771-0. J Gen Virol. 2005. PMID: 15784891

5

[Influences of the genotypes of HBV and HBeAg regarding their response to PEG-IFN in chronic hepatitis B patients].

Fan HB, Guo YB, Luo KX, Hou JL, Wang ZH, Zhang MX. Fan HB, et al. Zhonghua Gan Zang Bing Za Zhi. 2005 Jul;13(7):488-90. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16042879 Chinese.

6

Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China.

Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, Tan D, Xiao F, Ma S, Li W, Luo K, Naoumov NV, Hou J. Zeng G, et al. Among authors: hou j. J Viral Hepat. 2005 Nov;12(6):609-17. doi: 10.1111/j.1365-2893.2005.00657.x. J Viral Hepat. 2005. PMID: 16255762

7

[A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].

Zhao H, Si CW, Wei L, Wan MB, Ying YK, Hou JL, Niu JQ. Zhao H, et al. Zhonghua Gan Zang Bing Za Zhi. 2006 May;14(5):323-6. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16732903 Clinical Trial. Chinese.

8

A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B.

Zeng M, Mao Y, Yao G, Wang H, Hou J, Wang Y, Ji BN, Chang CN, Barker KF. Zeng M, et al. Among authors: hou j. Hepatology. 2006 Jul;44(1):108-16. doi: 10.1002/hep.21225. Hepatology. 2006. PMID: 16799983 Clinical Trial.

9

Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.

Zhao H, Kurbanov F, Wan MB, Yin YK, Niu JQ, Hou JL, Wei L, Wang GQ, Tanaka Y, Mizokami M, Si CW. Zhao H, et al. Clin Infect Dis. 2007 Feb 15;44(4):541-8. doi: 10.1086/511042. Epub 2007 Jan 11. Clin Infect Dis. 2007. PMID: 17243057 Clinical Trial.

10

[A double-blind, double-dummy, randomized, controlled study of entecavir versus lamivudine for treatment of chronic hepatitis B].

Yao GB, Zhu M, Wang YM, Xu DZ, Tan DM, Chen CW, Hou JL. Yao GB, et al. Zhonghua Nei Ke Za Zhi. 2006 Nov;45(11):891-5. Zhonghua Nei Ke Za Zhi. 2006. PMID: 17313873 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,969 results

Search Page

Filters